Meeting the New Regulatory Requirements in Sartan API Production
Manufacturer of APIs are now required to review their manufacturing processes and prove the absence of nitrosamine impurities. This whitepaper outlines the regulations and a case study on how Dr. Reddy’s Sartan API’s (such as Valsartan) already addresses future requirements.
You can review our Sartan portfolio by clicking on the following links:
Valsartan - https://api.drreddys.com/product/valsartan
Telmisartan - https://api.drreddys.com/product/telmisartan
Irbesartan - https://api.drreddys.com/product/irbesartan
Explore other Whitepapers:Know More
Please fill the Contact form below in order to view the white paper